Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC

Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide cancer surveillance for patients and their families.(00:32) Would each of you share a little bit about yourselves and your background? Dr. Shen? (01:25) Rihanna, could we have you give a little background about yourself as well? (01:48) Could you provide us with an overview of Lynch syndrome? (03:44) Can you expand on why genetic testing for Lynch syndrome is so important? (06:03) Who would benefit from Lynch testing? (07:51) Is Lynch syndrome the only type of inherited predisposition to colon cancer? (08:48) Does the healthcare provider order these tests, and what kind of samples should be considered in these patients? (10:50) Are there any limitations to the types of variants that can be detected by this test? And how does Mayo Clinic Laboratories ensure comprehensive results for patients?(14:24) How are the results used in patient care? (16:33) Could you summarize the benefits of these tests and of doing them at Mayo Clinic Laboratories?